A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).

导出 LinkOut

翻译打印收藏纠错

第一作者： Tomoaki,Morioka

第一单位： Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

作者： Tomoaki,Morioka ^[1] ; Masakazu,Takeuchi ^[2] ; Akichika,Ozeki ^[2] ; Masanori,Emoto ^[1]

作者单位： Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. ^[1] Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan. ^[2]

关键词 GLP‐1 dulaglutide phase III study randomized trial type 2 diabetes

主题词成年人(Adult);老年人(Aged);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2);双盲法(Double-Blind Method);用药计划表(Drug Administration Schedule);胰高血糖素样肽类(Glucagon-Like Peptides);低血糖症(Hypoglycemia);降血糖药(Hypoglycemic Agents);免疫球蛋白Fc片段(Immunoglobulin Fc Fragments);日本(Japan);重组融合蛋白质类(Recombinant Fusion Proteins);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1111/dom.15644

PMID 38715179

发布时间 2024-09-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes, obesity & metabolism

2024年26卷8期

3167-3175页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).

Diabetes, obesity & metabolism

相似文献

Diabetes, obesity & metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).

Diabetes, obesity & metabolism

相似文献

Diabetes, obesity & metabolism

相关期刊

检索历史清除